: Although FiO-determined PEEP is the standard in ARDS management, previous trials failed to show agreement on outcomes. Based on heterogeneous ARDS pathology, we evaluated the effect of LUS-determined PEEP on oxygenation and outcomes.
: In this prospective, controlled trial, we randomly assigned 60 patients into LUS-determined PEEP (group l) and FiO-determined PEEP (group II). LUS-determined PEEP was based on LUS aeration score. Primary outcome was P/F ratio, secondary outcomes were; static compliance, 28-day mortality, duration of MV and length of ICU-stay.
: P/F ratio was 266 ± 44.5 in group I, 233 ± 53.9 in group II. Static compliance was 54.8 ± 6.6 in group I, 45.9 ± 3.8 in group II. IQR of duration of MV was 4–6 with a median value of 5 in group l, 6–11.7 with a median value of 7.5 in group ll. 28-day mortality was 6.7% in group l, 30% in group ll. The relative risk of mortality in group II is more or less 5 times in group I (RR 4.87 with 95%CI of 1.492–15.893). IQR of organ dysfunction-free days was 16–19 with a median value of 18 in group l, 0–12 with a median value of 10 in group ll. IQR of MV-free days was 22–24 with a median value of 23 in group l, 0–22 with a median value of 20 in group ll.
: LUS-guided PEEP showed improved oxygenation, compliance and decreased mortality, organ dysfunction, duration of MV and ICU compared with FiO-guided PEEP.